Genesis Bank

Genesis Biotechnology Group (GBG) is a privately held consortium of vertically integrated companies focused on drug discovery, diagnostics, and healthcare services. The group operates several specialized divisions, including Genesis Drug Discovery & Development (GD3), which provides comprehensive CRO services from target validation to IND-enabling studies, and Genesis Diagnostics, a clinical laboratory specializing in molecular testing. GBG also maintains a significant biobank and cord blood banking facility, often referred to as Genesis Bank, which supports research and clinical applications in regenerative medicine. By integrating research, development, and clinical diagnostics, GBG aims to accelerate the transition of novel therapeutics from the laboratory to the clinic.